Clinical Trials Browser

Phase 2 × Neoplasms, Germ Cell and Embryonal × Bleomycin × Clear all

NCT01873326 2025-07-03

Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors

Phase 2 Active not recruiting

Neoplasms, Germ Cell and Embryonal

NCT02161692 2014-06-12

Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms